HEPATO CELLULAR CARCINOMA (HCC)
Clinical trials for HEPATO CELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new HEPATO CELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for HEPATO CELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Pre-Surgery immune boost stop liver Cancer's return?
Disease control Not yet recruitingThis study tests whether giving the immunotherapy drug atezolizumab before liver surgery can strengthen the body's immune response against liver cancer (hepatocellular carcinoma). About 30 patients will receive two doses before their operation. Researchers hope this approach migh…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE3 • Sponsor: University of Geneva, Switzerland • Aim: Disease control
Last updated Jun 23, 2026 23:34 UTC
-
New combo therapy aims to slash liver cancer recurrence after surgery
Disease control Not yet recruitingThis study tests whether combining local tumor treatments (TACE or ablation) with immunotherapy drugs (sintilimab and ipilimumab) before surgery can lower the chance of liver cancer coming back. It involves 105 adults with resectable liver cancer at intermediate-to-high risk of r…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
New combo therapy aims to shrink advanced liver and kidney tumors
Disease control Not yet recruitingThis study tests a new drug called WGI-0301 combined with the immunotherapy nivolumab in people with advanced liver or kidney cancer. The goal is to see if the combination is safe and can shrink tumors. About 230 adults aged 18 to 75 will take part, and the study does not use a p…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC